COMMUNIQUÉS West-GlobeNewswire
-
Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment
11/03/2026 -
TrimX Drops Metabolism Claims Evaluated: Latest Report About TrimX Liquid Thermogenic Formula Ingredient Research & Effectiveness for Men & Women
11/03/2026 -
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
11/03/2026 -
Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment
11/03/2026 -
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering
11/03/2026 -
The Leave-of-Absence Trap in Sham Peer Review Discussed in the Journal of American Physicians and Surgeons
10/03/2026 -
R1 and Heidi Announce Strategic Partnership to Improve Revenue Capture for Physician Groups and Healthcare Organizations
10/03/2026 -
Galapagos Receives Transparency Notifications from Bank of America
10/03/2026 -
To Restore Trust, Doctors Need to Re-commit to the Oath of Hippocrates, according to the Journal of American Physicians and Surgeons
10/03/2026 -
Medicare Advantage Mental Health Coverage in New York: $0–$30 Online Therapy Sessions
10/03/2026 -
Adverse Effects of COVID Vaccine on Skin Are Underrated, according to the Journal of American Physicians and Surgeons
10/03/2026 -
Longevity Based Releases New Report on Biohacking Recovery Technologies Used in CEO Jacob Gendron’s Longevity Routine
10/03/2026 -
Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum
10/03/2026 -
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update
10/03/2026 -
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
10/03/2026 -
Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026
10/03/2026 -
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
10/03/2026 -
BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering
10/03/2026 -
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
10/03/2026
Pages